CVSI 8-K 2026-11-12

CV Sciences, Inc. (CVSI) 8-K dated 2026-11-12 — accession 0001193125-26-458290.

CV Sciences, Inc. (CVSI) is a drug manufacturers - specialty & generic company listed on US.

CV Sciences, Inc. filed a 8-K on 2026-11-12. Accession 0001193125-26-458290.

This 8-K covers: Results of operations (Item 2.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported CVSI revenue for 2025-12-31 was $13.8M. Net income was -$958.0K. Revenue was down 12.2% from 2024-12-31 to 2025-12-31. CVSI currently screens at market cap $6.1M.

Not investment advice. The CVSI SEC hub lists recent forms. The stock page is the research view.